Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.1 USD | -0.70% | -5.44% | +78.45% |
05-08 | Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-07 | Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+78.45% | 534M | |
+7.15% | 113B | |
+11.09% | 106B | |
+0.93% | 22.27B | |
-12.30% | 22.22B | |
-5.94% | 19.43B | |
-37.85% | 17.87B | |
-6.04% | 17.24B | |
+7.87% | 14.29B | |
+34.95% | 12.52B |
- Stock Market
- Equities
- YMAB Stock
- News Y-mAbs Therapeutics, Inc.
- Guggenheim Downgrades Y-mAbs Therapeutics to Neutral From Buy